SARS-CoV-2

Haibo Li1,2, Hongyu Liu1,3, Hongping Wu1

  • 1National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China.

PubMed
概括

针对SARS-CoV-2突破性感染的免疫反应显示早期的2型,然后是1型细胞因子转移. 炎症标志物如S100A8/A9增加,在第7天和第5天分别出现抗体和T细胞.